Understanding the USD/CNY Central Rate Set by PBOC What is the USD/CNY Central Rate? The People’s Bank of China (PBOC) set the USD/CNY central rate for the trading session ahead on Thursday at 7.1708. This rate is compared to the previous day’s fix of 7.1696 and 7.2896 according to Reuters estimates. The USD/CNY central rate…
Welcome to the Quirky Corner Blog! A Closer Look at ARMOUR Residential REIT, Inc.’s Latest Announcement Hey there, quirky readers! Have you heard the news about ARMOUR Residential REIT, Inc.’s recent announcement? If not, let me fill you in on the juicy details. Sit back, relax, and let’s dive into this intriguing update. ARMOUR Residential…
AVAX: Riding the Crypto Avalanche to Success – Market Cap Skyrockets by 344%! Introduction Avalanche (AVAX), the blockchain platform known for its scalability and infrastructure, made significant strides in the fourth quarter (Q4) of 2023. According to a report by Messari, AVAX emerged as one of the best-performing tokens, driving the protocol to record notable…
Dr. Martens plc (OTCPK:DOCMF) Q3 2025 Sales/ Trading Statement Call January 27, 2025 4:00 AM ET Company Participants Ije Nwokorie – CEO Giles Wilson – CFO Conference Call Participants Kate Calvert – Investec John Stevenson – Peel Hunt Ben Rada Martin – Goldman Sachs Alison Lygo – Deutsche Numis Natasha Bonnet – Morgan Stanley Anne…
The New State-of-Art OligoPilot 2000™ Solid-Phase Synthesizer Adding cGMP Manufacturing Capacity for Oligonucleotide Programs The latest innovation in the field of oligonucleotide synthesis, the OligoPilot 2000™ solid-phase synthesizer, is set to revolutionize the way clinical and commercial oligonucleotide programs are supported and accelerated. With its cGMP manufacturing capacity, this state-of-the-art synthesizer is a game-changer in…
A Class Action Lawsuit Against Applied Therapeutics, Inc. New York, NY / Access Newswire / January 24, 2025 Pomerantz LLP has announced that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ:APLT). Investors who have potentially been affected by this case are advised to contact Danielle Peyton…
Investors who have suffered substantial losses in Super Micro Computer, Inc. (NASDAQ:SMCI) are urged to take action now. Hagens Berman is calling on affected investors to submit their losses as soon as possible. Class Periods: 1st Class Period: Aug. 10, 2021 – Aug. 26, 2024 2nd Class Period: Aug. 31, 2023 – Aug. 28, 2024…
InMed Pharmaceuticals Announces Share Consolidation Vancouver, British Columbia–(Newsfile Corp. – November 8, 2024) InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company”), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, has recently made a significant announcement. The Company has decided, pursuant to…
